DOSSIER · 13F Holders · Q2 2026Healthcare · Biological Products, (No Diagnostic Substances)
DNLI
DENALI THERAPEUTICS INC
311 institutions still hold DENALI THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 24823R105·Biological Products, (No Diagnostic Substances)·311 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
311 institutions reported DNLI in Q2 2026. BlackRock, Inc. leads at 14.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 16
291 more holders available. Log in →